Mr Alan Doherty
Consultant Urologist
MBBS, BSc, MD, FRCS (Urol), FEBU
Mr Alan Doherty
Alan is a Consultant Urologist and he completed his undergraduate training at The Middlesex Hospital before undergoing his surgical training at the Royal Marsden and Charing Cross Hospitals in London. Mr Doherty also studied at The Institute of Urology before taking up his position as a consultant urologist at Queen Elizabeth Hospital Birmingham, the largest urological cancer centre in the West Midlands, in 2001.
Mr Doherty’s commitment to using minimally invasive techniques based upon precision diagnostics where appropriate includes all major specialties in urological surgery, including laparoscopic cystectomy (bladder removal) and laparoscopic nephrectomy (kidney removal), both of which are only performed by a small number of UK surgeons. He has published extensively on prostate cancer, including articles in the Lancet.
Alan believes that focal therapy is a valuable option for the care of early prostate cancer and that it may be preferable to the active surveillance protocol for some men.
Mr Doherty was recently voted one of the UK’s top ten prostate cancer surgeons in a poll of urologists for the Daily Mail.
Professional Qualifications
- MBBS, University of London – 1988
- FRCS (Urol), Royal College of Surgeons of England – 1992
Professional Affiliations
- General Medical Council
- British Association of Urological Surgeons
- European Association of Urology
- American Urological Association
Current Appointment
- Queen Elizabeth Hospital, Birmingham
- Birmingham BMI The Priory Hospital
- Spire Parkway, Solihull
- Spire Little Aston Hospital, Birmingham
- Nuffield Health, Warwickshire
- The New Foscote Hospital, Banbury
- GenesisCare, Oxford
Selected Peer Reviewed Publications
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. New England Journal of Medicine. 2016.
- Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine. 2023.
- Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment. New England Journal of Medicine Evidence. 2023.
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.